Filter posts

2015 FDA Approvals: Highest Levels in Over a Decade

2015 was a blockbuster year for FDA approvals of novel new medicines, many of them …

Know Your IP Strategy: A Necessity for Technology Start-ups

The Licensing Executives Society Foundation invites start-up companies, with investments of less than $200,000, and …

Interstitial Cystitis: Understanding What It Is, and the Interstitial Cystitis Association’s Role...

If you mention Interstitial Cystitis (IC) to most people, including physicians, the majority of people …

The Liquid Gold Rush For Biopsies

Liquid biopsy is considered “liquid gold”. Estimates the global testing market to reach $20 billion …

Setting the Record Straight on Innovation and Drug Development

Modern biotechnology is a relatively young industry, but in just over 40 years, the entrepreneurs, …

Do Outcomes Matter When There Is Chronic Misalignment?

This piece by Allan L. Shaw was originally published in Life Science Leader. With over …

See What’s New at the 2015 BIO Investor Forum

The 2015 BIO Investor Forum is just two weeks away, and it’s gearing up to …

Biomarkets: Looking For The Hole In The Donut

This piece by Allan L. Shaw was originally published in Life Science Leader. The biopharma …

Politicking Biopharma Delays Cures

Forbes’ Matthew Herper ran a guest post from Robert Nelsen, cofounder and managing director of …

Warning: Don’t Let Bio-Euphoria Distract You from Being Disciplined

This piece by Allan L. Shaw was originally published in Life Science Leader. We currently …